1.4 Pharmacist License Renewal & Mandatory Continuing Education
Key Takeaways
- New Jersey pharmacist licenses expire biennially on April 30 of odd-numbered years (e.g., 2025, 2027).
- Pharmacists must complete a minimum of 30 continuing education (CE) credits per biennial renewal cycle, including at least 10 didactic (live) credits, at least 3 NJ pharmacy law credits, and at least 1 credit in prescription opioids.
- Up to 10 excess CE credits may be carried over into the next cycle if earned during the last 6 months of the biennial period (November 1 through April 30), but the 1 mandatory opioid credit cannot be carried over.
- Pharmacists authorized to perform Collaborative Drug Therapy Management (CDTM) must complete at least 10 CE credits per biennial cycle in each disease state or condition covered by the collaborative protocol.
- CE records and certificates must be retained for at least 5 years and produced upon Board audit; newly licensed pharmacists are exempt from CE requirements for their very first renewal.
Pharmacist License Renewal & Mandatory Continuing Education
Maintaining an active pharmacist license in New Jersey requires strict adherence to biennial renewal timelines and mandatory continuing professional education. Governed by N.J.A.C. 13:39-3.4 (License Renewal) and N.J.A.C. 13:39-3A.1 et seq. (Continuing Education), New Jersey’s regulatory scheme is designed to ensure that every practicing pharmacist maintains current knowledge of pharmacotherapy, state and federal jurisprudence, and public health initiatives—most notably opioid addiction mitigation.
The Biennial Renewal Cycle: Dates & Administrative Statuses
Pharmacist licenses in New Jersey do not renew on the licensee’s birthday or on the anniversary of initial licensure. Instead, New Jersey operates on a uniform, statewide biennial schedule.
New Jersey Pharmacist Renewal Timeline
(Odd-Numbered Years)
Nov 1 (Even Year) Apr 30 (Odd Year) May 30 (Odd Year)
│ │ │
▼ ▼ ▼
6-Month Carryover Window Statutory Expiration 30-Day Grace Period Ends
• Up to 10 excess CE credits • Renewal deadline • Late delinquent fee applies
earned here may carry over • Must complete 30 CE • License automatically SUSPENDED
• Opioid CE EXCLUDED credits if unrenewed after 30 days
Key Statutory Deadlines
- Expiration Date: All New Jersey pharmacist licenses expire biennially on April 30 of odd-numbered years (e.g., April 30, 2025; April 30, 2027; April 30, 2029).
- Renewal Notice: The Board distributes renewal notices at least 60 days prior to license expiration. However, failure to receive a renewal notice from the Board does not excuse a licensee from the statutory duty to renew in a timely manner.
- The 30-Day Grace Period: A licensee who fails to renew by April 30 has a 30-day grace period (until May 30) to submit the renewal application along with a late delinquent renewal fee. Practice during this 30-day window remains lawful.
- Administrative Suspension: If a pharmacist fails to renew within 30 days following the April 30 expiration, the license is automatically suspended without hearing for non-renewal. Practicing pharmacy with a suspended license constitutes the unlicensed practice of pharmacy, triggering criminal liability and severe civil penalties under N.J.S.A. 45:1-25.
Mandatory Continuing Education (CE) Breakdown
Under N.J.A.C. 13:39-3A.1, a pharmacist must complete a minimum of 30 continuing education credits (contact hours) during each biennial renewal period. One continuing education credit is defined as at least 50 minutes of continuous instruction.
The Board enforces strict subject-matter and instructional format allocations within the 30-credit total:
| Continuing Education Category | Minimum Credits Required | Permissible Instructional Formats & Topic Scope |
|---|---|---|
| Didactic Instruction (Live/Interactive) | At least 10 Credits | Must involve live, in-person educational sessions, live interactive webinars, or real-time broadcasts where the participant can interact directly with the presenter. Pre-recorded home-study videos do not qualify as didactic. |
| New Jersey Pharmacy Law | At least 3 Credits | Must focus specifically on New Jersey statutes, Board administrative rules (N.J.A.C. 13:39), state CDS rules (N.J.A.C. 13:45H), and relevant federal pharmacy jurisprudence. General commercial compliance does not qualify. |
| Prescription Opioid Drugs | At least 1 Credit | Mandatory topic areas: alternatives to opioid pain management, risks of opioid addiction and overdose, diversion detection and monitoring, and safe storage and disposal protocols. |
| General Pharmacy Subjects | Remaining 16 Credits | ACPE-accredited courses in pharmacotherapy, compounding, patient safety, disease state management, or clinical clinical services. |
[!IMPORTANT] The 30-10-3-1 Rule: Remember this core formula for the NJ MPJE:
- 30 Total Credits per 2-year cycle
- 10 Didactic (Live/Interactive) Credits
- 3 NJ Pharmacy Law Credits
- 1 Prescription Opioid Credit
Credit Carryover Allowance & Statutory Restrictions
A critical area frequently tested on the NJ MPJE is the CE carryover rule under N.J.A.C. 13:39-3A.1(b).
The 10-Credit / 6-Month Carryover Rule
If a pharmacist completes more than the mandatory 30 credits in a biennial renewal cycle, the pharmacist may carry over up to a maximum of 10 surplus credits into the immediately following biennial cycle, provided that:
- The surplus credits were earned during the last six (6) months of the preceding biennial period (i.e., between November 1 and April 30 of the odd-numbered year).
- Any credits earned prior to November 1 of that cycle are completely forfeited and cannot be carried forward.
The Absolute Opioid Carryover Exclusion
There is one vital, non-negotiable exception to the carryover rule:
- The mandatory 1 credit in prescription opioid drugs CANNOT BE CARRIED OVER under any circumstances.
- Every licensee must complete at least 1 fresh opioid credit during each distinct biennial renewal period. Surplus opioid credits earned in the last six months may carry over only as general credits, never satisfying the opioid requirement for the next cycle.
Collaborative Drug Therapy Management (CDTM) CE
Pharmacists who hold Board approval to engage in Collaborative Drug Therapy Management (CDTM) under N.J.A.C. 13:39-13 are subject to heightened continuing education standards:
- 10 Credits Per Disease State: In addition to maintaining standard competencies, a CDTM pharmacist must complete at least 10 continuing education credits in each specific disease state or condition governed by their collaborative practice protocol during each biennial cycle.
- Integration with the 30-Credit Total: These 10 disease-specific credits count toward the overall 30-credit requirement; they are not an additive burden beyond the 30 credits, unless the pharmacist participates in multiple protocols that collectively exceed 30 credits.
First-Time Renewal Exemption & Special Situations
New Jersey provides a specific statutory waiver for newly licensed pharmacists:
- First Renewal Exemption: A pharmacist who is licensed by examination during the second year of a biennial renewal cycle is completely exempt from all continuing education requirements for that initial renewal.
- First Year Licensure Pro-Ration: A pharmacist licensed during the first year of a biennial cycle must complete 15 credits (pro-rated half of 30), including at least 5 didactic credits, 1.5 law credits, and 1 opioid credit.
Audits, Record Retention, Inactive Status & Reinstatement
Audit & Record Retention Mandate
- Licensees affirm CE compliance under penalty of perjury on their renewal forms. The Board does not require submission of paper certificates at renewal.
- Instead, the Board conducts random post-renewal audits.
- Every pharmacist must maintain all physical CE completion certificates, ACPE transcripts, or CPE Monitor records for a minimum of five (5) years from the date of program completion.
- Failure to produce audit documentation upon Board demand constitutes professional misconduct, triggering monetary fines and mandatory make-up credits.
Inactive License Status
- A pharmacist may choose to place their license on inactive status at the time of renewal by paying an inactive fee.
- While inactive, the pharmacist is exempt from completing continuing education.
- Absolute Practice Prohibition: An inactive licensee is legally prohibited from engaging in the practice of pharmacy or identifying themselves as an active pharmacist in New Jersey.
- Reactivation Requirements: To reactivate an inactive license, the licensee must submit a formal application, pay the reactivation fee, and submit proof of completing 30 credits of CE for the current cycle (including the 10 didactic, 3 law, and 1 opioid credits) earned within the two years immediately preceding reactivation.
Reinstatement from Delinquent or Suspended Status
If a license was administratively suspended for failure to renew beyond the 30-day grace period, the licensee must apply for reinstatement:
- If suspended for less than 5 years: Pay all past-due delinquent renewal fees, submit a reinstatement application, and prove completion of 30 CE credits for each lapsed biennial cycle (subject to statutory Board maximums).
- If suspended for more than 5 years: The Board may mandate re-examination (passing the NJ MPJE and/or NAPLEX) and completion of practical internship hours prior to restoring the license.
A New Jersey licensed pharmacist is preparing for the biennial license renewal expiring on April 30 of an odd-numbered year. Which of the following credit allocations accurately reflects the mandatory continuing education (CE) requirements under N.J.A.C. 13:39-3A.1?
Pharmacist Elena completes 38 ACPE-approved continuing education credits during the biennial renewal cycle ending April 30, 2025. She earned 8 of these surplus credits in December 2024, including 2 credits in general pharmacotherapy and 1 credit in prescription opioid diversion. How many credits may Elena carry over to the subsequent biennial cycle ending April 30, 2027?
A New Jersey licensed pharmacist participates in a Collaborative Drug Therapy Management (CDTM) agreement with a physician covering the management of type 2 diabetes and hypertension. What additional continuing education requirement must this pharmacist fulfill under N.J.A.C. 13:39-13 during each biennial renewal period?